Neuropeptide Y and its C-terminal fragments acting on Y2 receptor: Raman and SERS spectroscopy studies

被引:15
|
作者
Domin, Helena [1 ]
Pieta, Ewa [2 ]
Piergies, Natalia [2 ]
Swiech, Dominika [2 ]
Kim, Younkyoo [3 ]
Proniewicz, Leonard M. [2 ]
Proniewicz, Edyta [4 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, PL-31343 Krakow, Poland
[2] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland
[3] Hankuk Univ Foreign Studies, Dept Chem, Yongin 449791, Kyunggi Do, South Korea
[4] AGH Univ Sci & Technol, Fac Foundry Engn, PL-30059 Krakow, Poland
关键词
Raman spectroscopy; RS; Surface-enhanced Raman Spectroscopy; SERS; Neuropeptide Y; NPY; Silver colloid; Y-2 receptor agonist; Native and mutated C-terminal NPY fragments; SILVER SURFACE SERS; PANCREATIC-POLYPEPTIDE; SECONDARY STRUCTURE; DFT CALCULATIONS; ADSORPTION MODE; AMINO-ACIDS; FT-RAMAN; S-S; ANALOGS; PROTEINS;
D O I
10.1016/j.jcis.2014.09.053
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
In this paper, we present spectroscopic studies of neuropeptide Y (NPY) and its native NPY3-36, NPY13-36, and NPY22-36 and mutated acetyl-(Leu(28,31))-NPY24-36 C-terminal fragments acting on Y-2 receptor. Since there is some evidence for the correlation between the SERS patterns and the receptor binding ability, we performed a detailed analysis for these compounds at the metal/water interface using Raman spectroscopy (RS) and surface-enhanced Raman spectroscopy (SERS) methods. Many studies have suggested that interactions of this kind are crucial for a variety of biomedical and biochemical phenomena. The identification of amino acids in these peptide sequences by SERS allowed us to determine which molecular fragments were responsible for the interaction with the silver nanoparticle surface. Our findings demonstrated that in all of the investigated compounds, the NPY32-36 C-terminal fragment (Thr(32)-Arg(33)-Gln(34)-Arg(36)-Tyr(36)NH(2)) was involved in the adsorption process onto metal substrate. The results of the present study suggest that the same molecular fragment interacts with the Y-2 receptor, what proved the usefulness of the SERS method in the study of these biologically active compounds. The search for analogs acting on Y-2 receptor may be important from the viewpoint of possible future clinical applications. (c) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [21] Design of the Y1-receptor-selective cyclic peptide based on the C-terminal sequence of neuropeptide Y
    Takebayashi, Y
    Koga, H
    Togami, J
    Inui, A
    Kurihara, H
    Koshiya, K
    Furuya, T
    Tanaka, A
    Murase, K
    JOURNAL OF PEPTIDE RESEARCH, 2000, 56 (06): : 409 - 415
  • [22] Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurones and cloning of the rat Y2 receptor
    St-Pierre, JA
    Dumont, Y
    Nouel, D
    Herzog, H
    Hamel, E
    Quirion, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (02) : 183 - 194
  • [23] Effect of Oral Nicotine Administration on Expression of Neuropeptide Y and Neuropeptide Y2 Receptor in Rat Brain
    Birdogan, Ali
    Salur, Elif
    Ozturk, Meliha
    Aypar, Buket
    Keser, Aysegul
    Kanit, Lutfiye
    Koylu, Ersin Oguz
    Balkan, Burcu
    Gozen, Oguz
    ACTA PHYSIOLOGICA, 2019, 227 : 37 - 37
  • [24] Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells
    Cattaneo, Stefano
    Bettegazzi, Barbara
    Crippa, Lucia
    Asth, Laila
    Regoni, Maria
    Soukupova, Marie
    Zucchini, Silvia
    Cantore, Alessio
    Codazzi, Franca
    Valtorta, Flavia
    Simonato, Michele
    EMBO REPORTS, 2024, 25 (10) : 4387 - 4409
  • [25] The Conformational Equilibrium of the Neuropeptide Y2 Receptor in Bilayer Membranes
    Krug, Ulrike
    Gloge, Anika
    Schmidt, Peter
    Becker-Baldus, Johanna
    Bernhard, Frank
    Kaiser, Anette
    Montag, Cindy
    Gauglitz, Marcel
    Vishnivetskiy, Sergey A.
    Gurevich, Vsevolod V.
    Beck-Sickinger, Annette G.
    Glaubitz, Clemens
    Huster, Daniel
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (52) : 23854 - 23861
  • [26] The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists
    Lunniss, Gillian E.
    Barnes, Ashley A.
    Barton, Nick
    Biagetti, Matteo
    Bianchi, Federica
    Blowers, Stephen M.
    Caberlotto, Laura
    Emmons, Amanda
    Holmes, Ian P.
    Montanari, Dino
    Norris, Ros
    Walters, Dewi J.
    Watson, Steve P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4022 - 4025
  • [27] The Conformational Equilibrium of the Neuropeptide Y2 Receptor in Bilayer Membranes
    Das Konformationsgleichgewicht des Neuropeptid-Y2-Rezeptors in Lipidmembranen
    Huster, Daniel (daniel.huster@medizin.uni-leipzig.de), 1600, John Wiley and Sons Inc (132): : 24062 - 24070
  • [28] Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists
    Mittapalli, Gopi Kumar
    Vellucci, Danielle
    Yang, Jun
    Toussaint, Marion
    Brothers, Shaun P.
    Wahlestedt, Claes
    Roberts, Edward
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 3916 - 3920
  • [29] Neuropeptide Y Y1 and Y2 Receptor mRNA Expression in the Prefrontal Cortex of Psychiatric SubjectsRelationship of Y2 Subtype to Suicidal Behavior
    Laura Caberlotto
    Yasmin L Hurd
    Neuropsychopharmacology, 2001, 25 : 91 - 97
  • [30] Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor
    Golombek, DA
    Biello, SM
    Rendon, RA
    Harrington, ME
    NEUROREPORT, 1996, 7 (07) : 1315 - 1319